 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
15 October 1995 | Volume 123 Issue 8 | Pages 572-583
Objective: To determine the genetic and clinical features of resistance to thyroid hormone in a study from a single institution.
Design: Prospective, controlled study.
Setting: National Institutes of Health.
Patients: 104 patients with resistance to thyroid hormone from 42 kindreds and 114 unaffected relatives sharing the patients' environmental and genetic back-grounds.
Measurements: Thyroid, cardiovascular, psychometric, hearing, speech, and growth testing; thyroid tests done at baseline and after TSH-releasing hormone stimulation; and DNA analysis for detection of mutations in the thyroid hormone receptor ß (TR ß) gene (exons 9 and 10). Assessment of tissue-specific compensation for resistance.
Results: Inheritance was autosomal dominant in 22 families, sporadic in 14 families, and unknown in 6 families. We found mutations in 25 kindreds (64 patients); 16 mutations were in exon 9 and 9 were in exon 10 of the TR ß gene. In persons with resistance to thyroid hormone, we measured the increased incidence of goiter (65%), attention-deficit hyperactivity disorder (60%), IQ less than 85 (38%), speech impediment (35%), and short stature (18%). We also described new clinical features, such as frequent ear, nose, and throat infections (56%); low weight-for-height in children (32%); hearing loss (21%); and cardiac abnormalities (18%). Genotype, age, whether the mother had resistance to thyroid hormone, and sex influenced the phenotype. Tissue resistance varied from kindred to kindred and involved, in decreasing order, the pituitary gland, the brain, the bone, the liver, and the heart.
Conclusions: This study underscores the incidence of classic features of resistance to thyroid hormone, describes new clinical characteristics of this condition for the first time, and stresses the heterogeneity of the phenotype.
Ann Inten Med. 1995; 123:572-583.
Author and Article Information
From the National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Disease, and National Cancer Institute, Bethesda, Maryland.
ARTICLE
Genetic and Clinical Features of 42 Kindreds with Resistance to Thyroid Hormone: The National Institutes of Health Prospective Study
Acknowledgments: The authors thank the study participants, their families, and their referring physicians and the nurses and fellows of the Clinical Center of the National Institutes of Health. They also thank Mitchell Gail MD, PhD, for expert statistical advice; David Pee, MPhil, for expert statistical computing; Suvimol Hill, MD, for bone age determination; Anita Pickus, MA, for audiologic assessment; Julio Panza, MD, for echocardiographic analysis; Pedro Martinez, MD, for attention-deficit hyperactivity disorder testing; and Jacob Robbins, MD, Rosemary Wong, MD, Richard Eastman, MD, and Miriam Levav, PhD, for critical review of the manuscript.
Requests for Reprints: Bruce D. Weintraub, MD, National Institutes of Health, MCEB, 10 Center Drive, MSC 1758, Building 10, Room 8D14, Bethesda, MD 20892-1758.
Current Author Addresses: Drs. Brucker-Davis, Skarulis, Wiggs, and Weintraub and Ms. Grace: Molecular and Cellular Endocrine Branch, NIDDK, National Institutes of Health, 10 Center Drive, MSC 1758, Bethesda, MD 20892-1758.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  T. Asua, A. Bilbao, M. A. Gorriti, J. A. Lopez-Moreno, M. del Mar Alvarez, M. Navarro, F. Rodriguez de Fonseca, A. Perez-Castillo, and A. Santos Implication of the Endocannabinoid System in the Locomotor Hyperactivity Associated with Congenital Hypothyroidism Endocrinology, May 1, 2008; 149(5): 2657 - 2666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D C Ferguson, Z Caffall, and M Hoenig Obesity increases free thyroxine proportionally to nonesterified fatty acid concentrations in adult neutered female cats J. Endocrinol., August 1, 2007; 194(2): 267 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ying, O. Araki, F. Furuya, Y. Kato, and S.-Y. Cheng Impaired Adipogenesis Caused by a Mutated Thyroid Hormone {alpha}1 Receptor Mol. Cell. Biol., March 15, 2007; 27(6): 2359 - 2371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mamanasiri, S. Yesil, A. M. Dumitrescu, X.-H. Liao, T. Demir, R. E. Weiss, and S. Refetoff Mosaicism of a Thyroid Hormone Receptor-{beta} Gene Mutation in Resistance to Thyroid Hormone J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3471 - 3477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lado-Abeal, A. M. Dumitrescu, X.-H. Liao, R. N. Cohen, J. Pohlenz, R. E. Weiss, M.-C. Lebrethon, A. Verloes, and S. Refetoff A De Novo Mutation in an Already Mutant Nucleotide of the Thyroid Hormone Receptor {beta} Gene Perpetuates Resistance to Thyroid Hormone J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1760 - 1767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tomita, D. R. Buchholz, and Y.-B. Shi Recruitment of N-CoR/SMRT-TBLR1 Corepressor Complex by Unliganded Thyroid Hormone Receptor for Gene Repression during Frog Development Mol. Cell. Biol., April 15, 2004; 24(8): 3337 - 3346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Ortiga-Carvalho, K. Hashimoto, C. C. Pazos-Moura, D. Geenen, R. Cohen, R. M. Lang, and F. E. Wondisford Thyroid Hormone Resistance in the Heart: Role of the Thyroid Hormone Receptor {beta} Isoform Endocrinology, April 1, 2004; 145(4): 1625 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Swanson, B. Gloss, D. D. Belke, M. Kaneshige, S.-Y. Cheng, and W. H. Dillmann Cardiac Expression and Function of Thyroid Hormone Receptor {beta} and Its PV Mutant Endocrinology, November 1, 2003; 144(11): 4820 - 4825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Buchholz, S.-C. V. Hsia, L. Fu, and Y.-B. Shi A Dominant-Negative Thyroid Hormone Receptor Blocks Amphibian Metamorphosis by Retaining Corepressors at Target Genes Mol. Cell. Biol., October 1, 2003; 23(19): 6750 - 6758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Suzuki, X.-Y. Zhang, D. Forrest, M. C. Willingham, and S.-Y. Cheng Marked Potentiation of the Dominant Negative Action of a Mutant Thyroid Hormone Receptor {beta} in Mice by the Ablation of One Wild-Type {beta} Allele Mol. Endocrinol., May 1, 2003; 17(5): 895 - 907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kopp Perspective: Genetic Defects in the Etiology of Congenital Hypothyroidism Endocrinology, June 1, 2002; 143(6): 2019 - 2024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Phillips, P. Rotman-Pikielny, J. Lazar, S. Ando, P. Hauser, M. C. Skarulis, F. Brucker-Davis, and P. M. Yen Extreme Thyroid Hormone Resistance in a Patient with a Novel Truncated TR Mutant J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5142 - 5147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ando, N. J. Sarlis, J. Krishnan, X. Feng, S. Refetoff, M. Q. Zhang, E. H. Oldfield, and P. M. Yen Aberrant Alternative Splicing of Thyroid Hormone Receptor in a TSH-Secreting Pituitary Tumor Is A Mechanism for Hormone Resistance Mol. Endocrinol., September 1, 2001; 15(9): 1529 - 1538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Yen Physiological and Molecular Basis of Thyroid Hormone Action Physiol Rev, July 1, 2001; 81(3): 1097 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. PEARL, R. E. WEISS, and M. A. STEIN Medical Mimics: Medical and Neurological Conditions Simulating ADHD Ann. N.Y. Acad. Sci., June 1, 2001; 931(1): 97 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Reutrakul, P. M. Sadow, S. Pannain, J. Pohlenz, G. A. Carvalho, P. E. Macchia, R. E. Weiss, and S. Refetoff Search for Abnormalities of Nuclear Corepressors, Coactivators, and a Coregulator in Families with Resistance to Thyroid Hormone without Mutations in Thyroid Hormone Receptor {beta} or {alpha} Genes J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3609 - 3617. [Abstract] [Full Text]
|
|
|
|
|
|
S. Ercan-Fang, H. L. Schwartz, C. N. Mariash, and J. H. Oppenheimer Quantitative Assessment of Pituitary Resistance to Thyroid Hormone from Plots of the Logarithm of Thyrotropin Versus Serum Free Thyroxine Index J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2299 - 2303. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Pazos-Moura, E. D. Abel, M.-E. Boers, E. Moura, T. G. Hampton, J. Wang, J. P. Morgan, and F. E. Wondisford Cardiac Dysfunction Caused by Myocardium-Specific Expression of a Mutant Thyroid Hormone Receptor Circ. Res., March 31, 2000; 86(6): 700 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Arpin, M. Pihlgren, A. Fraichard, D. Aubert, J. Samarut, O. Chassande, and J. Marvel Effects of T3R{alpha}1 and T3R{alpha}2 Gene Deletion on T and B Lymphocyte Development J. Immunol., January 1, 2000; 164(1): 152 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Safer, M. G. O’Connor, S. D. Colan, S. Srinivasan, S. R. Tollin, and F. E. Wondisford The Thyroid Hormone Receptor-{beta} Gene Mutation R383H Is Associated with Isolated Central Resistance to Thyroid Hormone J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3099 - 3109. [Abstract] [Full Text]
|
|
|
|
|
|
C. Asteria, O. Rajanayagam, T. N. Collingwood, L. Persani, R. Romoli, D. Mannavola, P. Zamperini, F. Buzi, F. Ciralli, V. K. K. Chatterjee, et al. Prenatal Diagnosis of Thyroid Hormone Resistance J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 405 - 410. [Abstract] [Full Text]
|
|
|
|
|
|
F. Brucker-Davis, E. H. Oldfield, M. C. Skarulis, J. L. Doppman, and B. D. Weintraub Thyrotropin-Secreting Pituitary Tumors: Diagnostic Criteria, Thyroid Hormone Sensitivity, and Treatment Outcome in 25 Patients Followed at the National Institutes of Health J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 476 - 486. [Abstract] [Full Text]
|
|
|
|
|
|
T. Tagami, W.-X. Gu, P. T. Peairs, B. L. West, and J. L. Jameson A Novel Natural Mutation in the Thyroid Hormone Receptor Defines a Dual Functional Domain That Exchanges Nuclear Receptor Corepressors and Coactivators Mol. Endocrinol., December 1, 1998; 12(12): 1888 - 1902. [Abstract] [Full Text]
|
|
|
|
|
|
R. E. Weiss, Y. Murata, K. Cua, Y. Hayashi, H. Seo, and S. Refetoff Thyroid Hormone Action on Liver, Heart, and Energy Expenditure in Thyroid Hormone Receptor {beta}-Deficient Mice Endocrinology, December 1, 1998; 139(12): 4945 - 4952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. McDonald, R. Wong, G. Goldstein, B. Weintraub, S.-y. Cheng, and J. N. Crawley Hyperactivity and Learning Deficits in Transgenic Mice Bearing a Human Mutant Thyroid Hormone beta 1 Receptor Gene Learn. Mem., September 1, 1998; 5(4): 289 - 301. [Abstract] [Full Text]
|
|
|
|
|
|
K.-h. Lin, X.-G. Zhu, H.-C. Hsu, S.-L. Chen, H.-y. Shieh, S.-T. Chen, P. McPhie, and S.-y. Cheng Dominant Negative Activity of Mutant Thyroid Hormone {alpha}1 Receptors from Patients with Hepatocellular Carcinoma Endocrinology, December 1, 1997; 138(12): 5308 - 5315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Olson and R. J. Koenig Thyroid Function in Rubinstein-Taybi Syndrome J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3264 - 3266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Behr, D. B. Ramsden, and U. Loos Deoxyribonucleic Acid Binding and Transcriptional Silencing by a Truncated c-erbA{beta}1 Thyroid Hormone Receptor Identified in a Severely Retarded Patient with Resistance to Thyroid Hormone J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1081 - 1087. [Abstract] [Full Text] [PDF]
|
|
Article
